Skip to content

Clinical trials

Carcinoma, Non-Small-Cell Lung trials in Singapore

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Carcinoma, Non-Small-Cell Lung Country / region: Singapore Clear all

193 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20012
20043
20052
20067
20076
200811
20098
20104
20116
20126
20139
20148
201516
20166
201712
20184
201916
202010
202114
20229
20236
20248
202511
20264

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed87
Active, not recruiting32
Recruiting29
Terminated29
Unknown status11
Approved for marketing2
Available2
Suspended1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals34
National University Hospital, Singapore15
Hoffmann-La Roche14
AstraZeneca13
National Cancer Centre, Singapore11
Bayer7
Boehringer Ingelheim7
Bristol-Myers Squibb7
Eli Lilly and Company6
Pfizer6

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma, Non-Small-Cell Lung193
Lung Neoplasms41
Neoplasms15
Colorectal Neoplasms12
Neoplasm Metastasis12
Carcinoma11
Melanoma11
Breast Neoplasms10
Carcinoma, Renal Cell10
Lung Diseases9

Trials

Showing 1 to 25 of 193. Each trial links to its page on Pharma Observatory.

93 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.